Page 1
Senior Director of Trade and Channel Management
Olema Oncology · San Francisco, California
$270k–300k
92 days ago
♡
Senior Director of Trade and Channel Management
Olema Oncology · Boston, Massachusetts
$270k–300k
92 days ago
♡
Associate Director, GMP Quality
Olema Oncology · San Francisco, California
$160k–180k
101 days ago
♡
Loading more openings…
You've reached the end of the list.
Senior Director of Trade and Channel Management
Olema Oncology · San Francisco, California
Pay
$270k–300k
Setting
On-site
Senior Director of Trade and Channel Management
San Francisco, California
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Senior Director of Trade and Channel Management
As the Senior Director of US Trade and Channel Management reporting to the Vice President of Market Access, you will be responsible for the strategic design, implementation, and optimization of a high-performing distribution network that ensures patient access while maximizing commercial value.
As a key leader within the U.S. Market Access function, you will oversee the total distribution ecosystem, including Specialty Pharmacy, Distribution and 3PL, while driving the long-term roadmap for trade operations and ensuring the organization is positioned to scale for future therapeutic innovations.
This role is based out of either our Boston or San Francisco office and will require approximately 20% travel.
Your work will primarily encompass:
Strategic Trade & Distribution Architecture
Define and lead the long-term U.S. distribution strategy and the design of a distribution network to support the launch of our future oncology product(s), including a selection process to select key externals partners (ie. SP, SD, 3PL, etc)
Provide active account management for specialty pharmacies, wholesalers/distributors, 3PL and other key trade partners to support product availability, service performance, and operational excellence
Establish, monitor, and manage key performance indicators, service-level expectations, inventory metrics, dispense data, and reporting requirements for channel partners; hold partners accountable while maintaining strong relationships
Ensure patient accessibility to product through trade partners and specialty pharmacies while supporting compliant processes and appropriate operational controls
Lead cross-functional teams with Patient Services, Commercial Operations/Analytics, Finance, IT, Field Sales, Legal/Compliance, Contracting, and Supply Chain to implement channel strategies, improve workflows, strengthen data quality, and track progress against established goals
Serve as the lead negotiator for enterprise-level contracts with major Wholesalers, Specialty Distributors, and Specialty Pharmacies to optimize channel fee structures and service requirements
Develop and implement an optimized distribution and contracting strategy which can anticipate industry shifts and proactively adapt the distribution model to maintain a competitive advantage
Oversee launch readiness for activities within the Trade and Distribution as we prepare for the launch our lead clinical asset as well as all pipeline assets and lifecycle management initiatives
Lead transformation initiatives in Trade & Distribution including process redesign, systems modernization, vendor optimization, and automation to improve efficiency, scalability, and data accuracy
Forecasting, Financial Governance & GTN
Own the trade-related components of the Gross-to-Net (GTN) strategy, providing executive leadership with visibility into channel costs, inventory fluctuations, and potential financial risks
Drive the integration of channel data into enterprise forecasting models to ensure high-accuracy demand planning and inventory management
Implement advanced analytics to monitor channel health, utilizing data-driven insights to mitigate product diversion, stockpiling, or supply disruptions
Establish and evolve KPIs and performance frameworks to assess and guide trade performance and strategic effectiveness
Collaborate with finance and other internal stakeholders to set up and manage systems/processes to track order to cash as well as fulfill government reporting obligations
Leadership and Organizational Influence
Collaborate with other members of the U.S. Market Access, Finance, and Commercial Operation, Supply Chain, Finance and other cross-functional team members to align trade strategy with broader corporate financial and patient access goals
Manage external partners and vendors to ensure effective and efficient management of day-to-day U.S. Trade and Distribution operations
Demonstrate high levels of emotional intelligence, situational awareness, and ability to build and influence a positive team culture
Actively participate and contribute to the Market Access leadership team and other formal or informal cross-functional teams as needed
Ideal Candidate Profile >>>
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Education and Required Skills
Education: Bachelor’s degree required; MBA or advanced degree in supply chain management or healthcare administration preferred
Experience: 15+ years of progressive leadership experience in pharmaceutical trade and distribution, with a proven track record of working with partners in specialty pharmacy, distribution and 3PL
Therapeutic Knowledge: Experience with oral oncology products is required and knowledge of the oncology provider space, specifically large and complex customers (GPOs, Institutions, IDNs, etc…) will be essential
Technical Expertise: Knowledge and experience with key Trade and Distribution technologies, well as with relevant federal and state legislation
Strategic Negotiation: Demonstrated success in leading high-stakes negotiations with national wholesalers and large-scale oncology providers
Launch Leadership: Extensive experience leading trade strategy for successful U.S. product launches, particularly in the oncology drug space, with relevant and recent experience launching oral oncology products
Cross-Functional Collaboration Skills: Demonstrated ability to work cross-functionally and to influence stakeholders with the aim of creating and maintaining an optimized distribution system/processes which optimizes GTN and prioritizes customer service
Performance Management: Works with vendors and external partners to drive performance while maintaining relationships
Analytical Skills: Set and maintain clear performance objectives and KPIs which ensure alignment with broader US commercial and global market access priorities
The base pay range for this position is expected to be $270,000 - $300,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV*
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Senior Director of Trade and Channel Management
Olema Oncology · Boston, Massachusetts
Pay
$270k–300k
Setting
On-site
Senior Director of Trade and Channel Management
Boston, Massachusetts
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Senior Director of Trade and Channel Management
As the Senior Director of Trade and Channel Management reporting to the Vice President of Market Access, you will be responsible for the strategic design, implementation, and optimization of a high-performing distribution network that ensures patient access while maximizing commercial value.
As a key leader within the U.S. Market Access function, you will oversee the total distribution ecosystem, including Specialty Pharmacy, Distribution and 3PL, while driving the long-term roadmap for trade operations and ensuring the organization is positioned to scale for future therapeutic innovations.
This role is based out of either our Boston or San Francisco office and will require approximately 20% travel.
Your work will primarily encompass:
Strategic Trade & Distribution Architecture
Define and lead the long-term U.S. distribution strategy and the design of a distribution network to support the launch of our future oncology product(s), including a selection process to select key externals partners (ie. SP, SD, 3PL, etc)
Provide active account management for specialty pharmacies, wholesalers/distributors, 3PL and other key trade partners to support product availability, service performance, and operational excellence
Establish, monitor, and manage key performance indicators, service-level expectations, inventory metrics, dispense data, and reporting requirements for channel partners; hold partners accountable while maintaining strong relationships
Ensure patient accessibility to product through trade partners and specialty pharmacies while supporting compliant processes and appropriate operational controls
Lead cross-functional teams with Patient Services, Commercial Operations/Analytics, Finance, IT, Field Sales, Legal/Compliance, Contracting, and Supply Chain to implement channel strategies, improve workflows, strengthen data quality, and track progress against established goals
Serve as the lead negotiator for enterprise-level contracts with major Wholesalers, Specialty Distributors, and Specialty Pharmacies to optimize channel fee structures and service requirements
Develop and implement an optimized distribution and contracting strategy which can anticipate industry shifts and proactively adapt the distribution model to maintain a competitive advantage
Oversee launch readiness for activities within the Trade and Distribution as we prepare for the launch our lead clinical asset as well as all pipeline assets and lifecycle management initiatives
Lead transformation initiatives in Trade & Distribution including process redesign, systems modernization, vendor optimization, and automation to improve efficiency, scalability, and data accuracy
Forecasting, Financial Governance & GTN
Own the trade-related components of the Gross-to-Net (GTN) strategy, providing executive leadership with visibility into channel costs, inventory fluctuations, and potential financial risks
Drive the integration of channel data into enterprise forecasting models to ensure high-accuracy demand planning and inventory management
Implement advanced analytics to monitor channel health, utilizing data-driven insights to mitigate product diversion, stockpiling, or supply disruptions
Establish and evolve KPIs and performance frameworks to assess and guide trade performance and strategic effectiveness
Collaborate with finance and other internal stakeholders to set up and manage systems/processes to track order to cash as well as fulfill government reporting obligations
Leadership and Organizational Influence
Collaborate with other members of the U.S. Market Access, Finance, and Commercial Operation, Supply Chain, Finance and other cross-functional team members to align trade strategy with broader corporate financial and patient access goals
Manage external partners and vendors to ensure effective and efficient management of day-to-day U.S. Trade and Distribution operations
Demonstrate high levels of emotional intelligence, situational awareness, and ability to build and influence a positive team culture
Actively participate and contribute to the Market Access leadership team and other formal or informal cross-functional teams as needed
Ideal Candidate Profile >>>
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Education and Required Skills
Education: Bachelor’s degree required; MBA or advanced degree in supply chain management or healthcare administration preferred
Experience: 15+ years of progressive leadership experience in pharmaceutical trade and distribution, with a proven track record of working with partners in specialty pharmacy, distribution and 3PL
Therapeutic Knowledge: Experience with oral oncology products is required and knowledge of the oncology provider space, specifically large and complex customers (GPOs, Institutions, IDNs, etc…) will be essential
Technical Expertise: Knowledge and experience with key Trade and Distribution technologies, well as with relevant federal and state legislation
Strategic Negotiation: Demonstrated success in leading high-stakes negotiations with national wholesalers and large-scale oncology providers
Launch Leadership: Extensive experience leading trade strategy for successful U.S. product launches, particularly in the oncology drug space, with relevant and recent experience launching oral oncology products
Cross-Functional Collaboration Skills: Demonstrated ability to work cross-functionally and to influence stakeholders with the aim of creating and maintaining an optimized distribution system/processes which optimizes GTN and prioritizes customer service
Performance Management: Works with vendors and external partners to drive performance while maintaining relationships
Analytical Skills: Set and maintain clear performance objectives and KPIs which ensure alignment with broader US commercial and global market access priorities
The base pay range for this position is expected to be $270,000 - $300,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV*
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Associate Director, GMP Quality
Olema Oncology · Boston, Massachusetts
Pay
$160k–180k
Setting
On-site
Associate Director, GMP Quality
Boston, Massachusetts
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Associate Director GMP Quality
As the Associate Director, GMP Quality, reporting to the Head of GMP Quality, you will be responsible for oversight of GMP activities pertaining to Olema’s products, both clinical and commercial. The focus of this role will be oversight of the manufacture of small molecule drug substances (Active Pharmaceutical Ingredients). There will be associated responsibilities for reviewing Analytical Development / Quality Control results. In this position you will perform GMP activities such as, but not limited to, review of Certificate of Analysis, Batch Disposition, Person in Plant oversight, and supporting Supplier compliance. In this role you will also collaborate with other functional teams such CMC, Regulatory and Supply Chain to prepare submissions, ensure quality and compliance for Olema’s products.
This role will be based out of our San Francisco or Boston office and will require 10-15% travel, some international.
Your work will primarily encompass:
Batch disposition/ release for Clinical Trial Materials and Commercial batches
Perform technical review, quality oversight and approvals Master Batch records and Executed Batch records
Review and approval of CMO Deviations, CAPA, and Change Controls and opening of internal shadow records when required
Perform technical review of Quality Control records such as Certificate of Analysis, Analytical Testing, Method Validation and Stability reports
Operational oversight of Olema’s CMOs as specified in quality agreements; this may include periodic visits to CMOs
Represent Olema as Person in Plant (PIP) when critical processing occurs as necessary
Support Pre-Approval Inspection readiness for NDA / commercial launch
Review sections of New Drug Applications for content and accuracy
Review Quality Agreements and support Supplier audits as necessary
Interact with Qualified Persons (QP) to facilitate the release of Clinical and Commercial product
Generate metrics for Quality Management Reviews
Contribute and participate in Annual Product Quality Reviews of commercial products
Represent GMP Quality during internal and regulatory inspections
Author Quality department SOPs as required
Ideal Candidate Profile >>> Key Requirements
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Knowledge:
Bachelor’s degree is required; advanced degree (MS, PharmD, PhD) preferred
Extensive understanding and knowledge of industry standards, concepts and current cGMP (21 CFR Parts 210 and 211), EudraLex Volume 4, ICH Q7 and other agency standards and guidance as they relate to GMP Quality Assurance
Experience:
Minimum of 8 years' work experience in an FDA regulated Pharmaceutical GMP / GMP QA role
Experience with small molecule synthesis and analytical test record review
Prior experience with NDA/BLA submission and commercial launch for pharmaceutical products
Familiarity with effective Quality Systems and performing robust investigations
Experience with Health Authority filings and EU QP queries
Experience managing CMO relationships and supporting CMO inspections
Experience with Quality Management Systems such as Veeva or TrackWise
Proficient in Word, Excel, PowerPoint, SharePoint
Attributes:
Demonstrated proven track record of leadership, communication, adaptability, and collaboration
Communicate decisions and recommendations with clear background and justification
A strong team player with the ability to focus on project objectives with an emphasis on quality
Clear, concise writing skills and good verbal presentation skills
Ability to prioritize, work independently, and mindfully engage with others
The base pay range for this position is expected to be $160,000 - $180,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Associate Director, GMP Quality
Olema Oncology · San Francisco, California
Pay
$160k–180k
Setting
On-site
Associate Director, GMP Quality
San Francisco, California
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Associate Director GMP Quality
As the Associate Director, GMP Quality, reporting to the Head of GMP Quality, you will be responsible for oversight of GMP activities pertaining to Olema’s products, both clinical and commercial. The focus of this role will be oversight of the manufacture of small molecule drug substances (Active Pharmaceutical Ingredients). There will be associated responsibilities for reviewing Analytical Development / Quality Control results. In this position you will perform GMP activities such as, but not limited to, review of Certificate of Analysis, Batch Disposition, Person in Plant oversight, and supporting Supplier compliance. In this role you will also collaborate with other functional teams such CMC, Regulatory and Supply Chain to prepare submissions, ensure quality and compliance for Olema’s products.
This role will be based out of our San Francisco or Boston office and will require 10-15% travel, some international.
Your work will primarily encompass:
Batch disposition/ release for Clinical Trial Materials and Commercial batches
Perform technical review, quality oversight and approvals Master Batch records and Executed Batch records
Review and approval of CMO Deviations, CAPA, and Change Controls and opening of internal shadow records when required
Perform technical review of Quality Control records such as Certificate of Analysis, Analytical Testing, Method Validation and Stability reports
Operational oversight of Olema’s CMOs as specified in quality agreements; this may include periodic visits to CMOs
Represent Olema as Person in Plant (PIP) when critical processing occurs as necessary
Support Pre-Approval Inspection readiness for NDA / commercial launch
Review sections of New Drug Applications for content and accuracy
Review Quality Agreements and support Supplier audits as necessary
Interact with Qualified Persons (QP) to facilitate the release of Clinical and Commercial product
Generate metrics for Quality Management Reviews
Contribute and participate in Annual Product Quality Reviews of commercial products
Represent GMP Quality during internal and regulatory inspections
Author Quality department SOPs as required
Ideal Candidate Profile >>> Key Requirements
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Knowledge:
Bachelor’s degree is required; advanced degree (MS, PharmD, PhD) preferred
Extensive understanding and knowledge of industry standards, concepts and current cGMP (21 CFR Parts 210 and 211), EudraLex Volume 4, ICH Q7 and other agency standards and guidance as they relate to GMP Quality Assurance
Experience:
Minimum of 8 years' work experience in an FDA regulated Pharmaceutical GMP / GMP QA role
Experience with small molecule synthesis and analytical test record review
Prior experience with NDA/BLA submission and commercial launch for pharmaceutical products
Familiarity with effective Quality Systems and performing robust investigations
Experience with Health Authority filings and EU QP queries
Experience managing CMO relationships and supporting CMO inspections
Experience with Quality Management Systems such as Veeva or TrackWise
Proficient in Word, Excel, PowerPoint, SharePoint
Attributes:
Demonstrated proven track record of leadership, communication, adaptability, and collaboration
Communicate decisions and recommendations with clear background and justification
A strong team player with the ability to focus on project objectives with an emphasis on quality
Clear, concise writing skills and good verbal presentation skills
Ability to prioritize, work independently, and mindfully engage with others
The base pay range for this position is expected to be $160,000 - $180,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV*
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Director, Safety Sciences
Olema Oncology · Boston, Massachusetts
Pay
$235k
Setting
On-site
Director, Safety Sciences
Boston, Massachusetts
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Director, Safety Sciences
As the Director, Safety Sciences reporting to the Senior Director, Safety Science you will provide leadership for the strategy, evaluation, and communication of clinical safety data across the development lifecycle, supporting global regulatory submissions and ongoing product development. Oversee the development of key safety deliverables for NDA/BLA filings, lead integrated benefit-risk assessments, and drive cross-functional alignment on safety strategy and regulatory interactions. Ensure compliance with FDA, EMA, ICH, and other global regulatory requirements while enabling proactive risk management and informed benefit-risk decision-making.
This role is based out of our San Francisco or Boston office and will require less than 10% travel
Your work will primarily encompass:
Lead the preparation of safety components for NDA/BLA submissions, ensuring alignment with FDA, EMA, and ICH requirements.
Author and review integrated safety documents, including the Integrated Summary of Safety (ISS), Summary of Clinical Safety (SCS), benefit-risk assessments, and clinical overviews.
Collaborate and support in the development of safety narratives, datasets, analyses, and submission-ready safety deliverables for regulatory filings.
Conduct comprehensive evaluation and integration of safety data from clinical studies to support overall benefit-risk assessment for marketing applications.
Collaborate with Clinical Development, Biostatistics, Regulatory Affairs, Medical Writing, and Programming teams to develop safety strategies and analyses supporting regulatory submissions.
Prepare and review safety sections of key regulatory documents, including NDA/BLA modules, Investigator Brochures, protocols, informed consent forms, briefing books, and Company Core Data Sheets (CCDS).
Lead development and maintenance of Risk Management Plans (RMPs), Risk Evaluation and Mitigation Strategies (REMS), and other risk management documents as applicable.
Participate in preparation and overall regulatory agency meetings (FDA, EMA, PMDA, MHRA, etc.), including safety briefing materials and responses to health authority questions.
Partner with QA in regulatory inspections and audits, ensuring submission-related safety documentation is inspection ready.
Review and interpret safety findings from clinical trials, literature, and post-marketing data to support regulatory decision-making and labeling recommendations.
Contribute to the development of product labeling, including safety sections of prescribing information, package inserts, and related risk communication materials.
Oversee aggregate safety reporting activities, including DSURs, PBRERs/PSURs, PADERs, and other periodic safety reports required during product development and registration.
Provide strategic safety input for submission timelines, filing readiness assessments, and regulatory risk mitigation plans.
Ensure compliance with applicable FDA, EU, ICH, and global pharmacovigilance regulations governing clinical safety and marketing authorization applications.
Lead cross-functional safety review meetings and communicate safety findings effectively to internal stakeholders, regulatory authorities, and external partners.
Ideal Candidate Profile >>>
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Knowledge:
MD, PhD in the field of medical/biological science, PharmD, or RN degree
Small Molecule and Oncology is a must
Experience:
Minimum of 8+ (MD, PhD, PharmD) or 10+ (RN) years of pharmacovigilance/drug safety experience in biopharmaceutical industry
Late phase clinical development and registration experience; NDA/BLA submissions and submission readiness planning
Experience with clinical safety data integration and ISS authoring/review
Proven experience with benefit-risk assessments and regulatory justification
Experience with labeling negotiations and safety labeling strategy
Demonstrated success leading health authority meeting preparation and regulatory responses
Ability to apply relevant FDA, EU and ICH guidelines, initiatives and regulations governing pharmacovigilance activities, along with regulatory response management
Familiar with the clinical database/EDC, CTD/eCTD knowledge
Ability to work with the safety database for purposes of clinical/medical case review and simple queries
Experience working with business partners and managing safety vendors
Track record of leading, managing, mentoring and teaching new/junior team members
Actively participated in process improvement initiatives e.g. the development and maintenance of relevant SOPs and supporting documents
Attributes:
Able to manage time effectively, prioritize competing tasks, and consistently meet deadlines
Strong verbal and written skills to convey safety findings and recommendations with clarity
Excellent analytical, problem-solving, strategic planning, and interpersonal skills
Self-motivated and enthusiastic; fast learner who can identify the core project challenges and expeditiously change courses as required in a fast-paced organization
Demonstrates sound judgment, professionalism, and strong ethical standards
The base pay range for this position is expected to be $235,000-$255,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Do you reside within a within a 50 mile radius of San Francisco CA or Cambridge MA?*
Select...
Are you a MD, PhD, PharmD, or RN?*
Select...
Do you have direct pharmacovigilance/drug safety experience supporting small molecule oncology products?*
Select...
Have you led late stage clinical development submission activities, including submission readiness planning?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Director, Safety Sciences
Olema Oncology · San Francisco, California
Pay
$235k–255k
Setting
On-site
Director, Safety Sciences
San Francisco, California
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Director, Safety Sciences
As the Director, Safety Sciences reporting to the Senior Director, Safety Science you will provide leadership for the strategy, evaluation, and communication of clinical safety data across the development lifecycle, supporting global regulatory submissions and ongoing product development. Oversee the development of key safety deliverables for NDA/BLA filings, lead integrated benefit-risk assessments, and drive cross-functional alignment on safety strategy and regulatory interactions. Ensure compliance with FDA, EMA, ICH, and other global regulatory requirements while enabling proactive risk management and informed benefit-risk decision-making.
This role is based out of our San Francisco or Boston office and will require less than 10% travel.
Your work will primarily encompass:
Lead the preparation of safety components for NDA/BLA submissions, ensuring alignment with FDA, EMA, and ICH requirements.
Author and review integrated safety documents, including the Integrated Summary of Safety (ISS), Summary of Clinical Safety (SCS), benefit-risk assessments, and clinical overviews.
Collaborate and support in the development of safety narratives, datasets, analyses, and submission-ready safety deliverables for regulatory filings.
Conduct comprehensive evaluation and integration of safety data from clinical studies to support overall benefit-risk assessment for marketing applications.
Collaborate with Clinical Development, Biostatistics, Regulatory Affairs, Medical Writing, and Programming teams to develop safety strategies and analyses supporting regulatory submissions.
Prepare and review safety sections of key regulatory documents, including NDA/BLA modules, Investigator Brochures, protocols, informed consent forms, briefing books, and Company Core Data Sheets (CCDS).
Lead development and maintenance of Risk Management Plans (RMPs), Risk Evaluation and Mitigation Strategies (REMS), and other risk management documents as applicable.
Participate in preparation and overall regulatory agency meetings (FDA, EMA, PMDA, MHRA, etc.), including safety briefing materials and responses to health authority questions.
Partner with QA in regulatory inspections and audits, ensuring submission-related safety documentation is inspection ready.
Review and interpret safety findings from clinical trials, literature, and post-marketing data to support regulatory decision-making and labeling recommendations.
Contribute to the development of product labeling, including safety sections of prescribing information, package inserts, and related risk communication materials.
Oversee aggregate safety reporting activities, including DSURs, PBRERs/PSURs, PADERs, and other periodic safety reports required during product development and registration.
Provide strategic safety input for submission timelines, filing readiness assessments, and regulatory risk mitigation plans.
Ensure compliance with applicable FDA, EU, ICH, and global pharmacovigilance regulations governing clinical safety and marketing authorization applications.
Lead cross-functional safety review meetings and communicate safety findings effectively to internal stakeholders, regulatory authorities, and external partners.
Ideal Candidate Profile >>>
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Knowledge:
MD, PhD in the field of medical/biological science, PharmD, or RN degree
Small Molecule and Oncology is a must
Experience:
Minimum of 8+ (MD, PhD, PharmD) or 10+ (RN) years of pharmacovigilance/drug safety experience in biopharmaceutical industry
Late phase clinical development and registration experience; NDA/BLA submissions and submission readiness planning
Experience with clinical safety data integration and ISS authoring/review
Proven experience with benefit-risk assessments and regulatory justification
Experience with labeling negotiations and safety labeling strategy
Demonstrated success leading health authority meeting preparation and regulatory responses
Ability to apply relevant FDA, EU and ICH guidelines, initiatives and regulations governing pharmacovigilance activities, along with regulatory response management
Familiar with the clinical database/EDC, CTD/eCTD knowledge
Ability to work with the safety database for purposes of clinical/medical case review and simple queries
Experience working with business partners and managing safety vendors
Track record of leading, managing, mentoring and teaching new/junior team members
Actively participated in process improvement initiatives e.g. the development and maintenance of relevant SOPs and supporting documents
Attributes:
Able to manage time effectively, prioritize competing tasks, and consistently meet deadlines
Strong verbal and written skills to convey safety findings and recommendations with clarity
Excellent analytical, problem-solving, strategic planning, and interpersonal skills
Self-motivated and enthusiastic; fast learner who can identify the core project challenges and expeditiously change courses as required in a fast-paced organization
Demonstrates sound judgment, professionalism, and strong ethical standards
The base pay range for this position is expected to be $235,000 - $255,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV*
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Do you reside within a within a 50 mile radius of San Francisco CA or Cambridge MA?*
Select...
Are you a MD, PhD, PharmD, or RN?*
Select...
Do you have direct pharmacovigilance/drug safety experience supporting small molecule oncology products?*
Select...
Have you led late stage clinical development submission activities, including submission readiness planning?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Senior Medical Science Liaison (Southeast Region)
Olema Oncology · Remote
Pay
Not listed
Setting
Remote
Senior Medical Science Liaison (Southeast Region)
Remote
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Senior Medical Science Liaison, Southeast Region
As the Senior Medical Science Liaison reporting to the Director, Medical Science Liaison, you will serve as a scientific expert and external representative for Olema. You will engage with key opinion leaders and healthcare providers to facilitate scientific exchange, communicate medical and clinical information, and support Olema's medical affairs objectives.
This is a field-based role (Southeast Region) that requires 50% travel.
Your work will primarily encompass:
Identify, connect, cultivate and maintain relationships with key opinion leaders, healthcare professionals and researchers in both academic and community centers within the assigned territory
Develop and execute territory engagement plans that aligned with medical affairs strategies to optimize impact in the field
Provide medical and scientific insights to internal stakeholders to inform product development and strategy
Facilitate and support new and ongoing clinical research in collaboration with medical and clinical operations teams (company-sponsored trials, investigator-initiated studies, and other collaborative initiatives)
Serve as a trusted scientific and medical resource, providing accurate and updated information about Olema therapies and research externally
Conduct medical education programs and presentations to healthcare professionals as needed to relay information about Olema’s products and research
And will also include:
Maintain up-to-date knowledge of developments in breast cancer research, treatment options, and disease management
Professionally represent Olema at select medical and scientific conferences and meetings
Serve as scientific resource to commercial partners, as appropriate, to support activities
Ideal Candidate Profile >>>
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Knowledge:
Doctorate degree (MD, PharmD or PhD)
Oncology therapeutic expertise required
Strong analytical skills demonstrating the ability to identify and understand complex issues/problems
Strong communication and presentation skills required
Experience:
Minimum of 5 years of medical affairs or field medical experience with a verifiable record of high performance
Prior experience in solid tumors required with breast cancer experience strongly preferred
Clinical trial development and drug launch experience strongly preferred
Field medical experience within the Southeast region strongly preferred
Attributes:
Simplifying complex information into clear, concise messages to effectively communicate the company story
Excellent communication skills – written, verbal, presentation, interpersonal
Serving in a high-visibility role and making public presentations to a variety of audiences
Ability to work in cross-functional teams with internal stakeholders
Anticipating needs, meeting tight deadlines, being proactive, and exercising independent decision-making
Managing the communication of sensitive and confidential information
This is a role where judgement, tact, flexibility and resourcefulness are key
Strong relationship-building and negotiating skills
Highly organized with an attention to detail and ability to meet timelines in a fast-paced environment
Strong project management skills; can work on multiple projects simultaneously and effectively prioritize workload
The base pay range for this position is expected to be $185,000 - $200,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV*
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Please confirm which state in the Southeast you currently reside in*
Select...
Please confirm which doctorate degree you hold.*
Select...
Do you have at least 5 years of Medical Affairs and/or Field Medical (MSL) experience?*
Select...
Do you have direct Medical Affairs or Field Medical experience supporting solid tumor oncology products or clinical programs?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Director, Clinical Science
Olema Oncology · Boston, Massachusetts
Pay
$220k–245k
Setting
On-site
Director, Clinical Science
Boston, Massachusetts
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Director, Clinical Science
As the Director, Clinical Science reporting to the Vice President, Clinical Science, you will play a key role in one of our ongoing clinical studies. You will work collaboratively in a multi-disciplinary team setting including Clinical Operations, Medical Monitors, Data Management, Biostatistics, Clinical Pharmacology, Regulatory and Program Management, in the planning, conduct and analysis of clinical trials.
Your job contributes to and supports Olema’s mission of developing therapies that offer the potential to improve outcomes for women living with cancer.
This role is based out of our San Francisco, CA or Cambridge, MA office and will require up to 20% travel.
Your work will primarily encompass:
Writing of technical and clinical documents including protocols, amendments, investigator’s brochures, and the clinical sections of regulatory documents
Working with the study team to identify and track any potential safety events within a given trial
Interacting with investigators and thought leaders in oncology to facilitate the design of clinical synopses and protocols
Evaluate the safety, pharmacology, and efficacy of ongoing studies in close collaboration with the medical monitor and the safety, pharmacology and clinical operations teams
Organizing and performing the study level and individual subject level analysis of the clinical trial data to gain insights and develop strategies for the clinical study report (CSR) writing
Contributing to the writing and/or review product specific abstracts, publications and supporting the development of presentations for scientific meetings
Maintaining clinical and technical expertise in the therapeutic area of oncology
Attending scientific meetings pertinent to clinical science activities
And will also include:
Collaborating with the Medical Monitor on review of enrollment packets, clinical development plans and scientific presentations
Collaborating with Clinical Operations and other internal study teams to develop Informed Consent Forms, Case Report Forms and CRF instructions
Participating in ongoing clinical data review in collaboration with a cross functional team
Collaborating with Clinical Operations and other team members in the development of agendas, training materials and presentation for site visits, investigator meetings and other study related activities
Ensuring adherence to Olema’s Standard Operation Procedures and values, and maintaining the highest level of ethical behavior by leading by example
Ideal Candidate Profile >>>
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Knowledge:
Advanced degree such as a PhD or PharmD is strongly preferred
Experience in oncology clinical development is required
Comprehensive knowledge of oncology clinical trial implementation and drug development process
Demonstrated understanding of the clinical drug development process to execute drug development strategic plans and meet milestones
Experience:
A minimum of 8 years’ experience in biotech/pharmaceutical industry is required
Strong knowledge of Good Clinical Practices (GCP), FDA, and EMEA/CHMP regulations and guidelines; familiarity with other international regulatory requirements is a plus
Proactively identifying challenges/problems and proposing solutions with a strong sense of urgency
Demonstrated success motivating both internal and external team members and collaborators, fostering and nurturing teamwork
Attributes:
Strong attention to detail
Ability to interact effectively within a cross functional team
Excellent written and oral communication skills
Ability to work in a diverse and dynamic cross-functional team
Passionate about the drug-development process
Self-starter who thrives in a fast-paced environment
The base pay range for this position is expected to be $220,000 - $250,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Director, Clinical Science
Olema Oncology · San Francisco, California
Pay
$220k–245k
Setting
On-site
Director, Clinical Science
San Francisco, California
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Director, Clinical Science
As the Director, Clinical Science reporting to the Vice President, Clinical Science, you will play a key role in one of our ongoing clinical studies. You will work collaboratively in a multi-disciplinary team setting including Clinical Operations, Medical Monitors, Data Management, Biostatistics, Clinical Pharmacology, Regulatory and Program Management, in the planning, conduct and analysis of clinical trials.
Your job contributes to and supports Olema’s mission of developing therapies that offer the potential to improve outcomes for women living with cancer.
This role is based out of our San Francisco, CA or Cambridge, MA office and will require up to 20% travel.
Your work will primarily encompass:
Writing of technical and clinical documents including protocols, amendments, investigator’s brochures, and the clinical sections of regulatory documents
Working with the study team to identify and track any potential safety events within a given trial
Interacting with investigators and thought leaders in oncology to facilitate the design of clinical synopses and protocols
Evaluate the safety, pharmacology, and efficacy of ongoing studies in close collaboration with the medical monitor and the safety, pharmacology and clinical operations teams
Organizing and performing the study level and individual subject level analysis of the clinical trial data to gain insights and develop strategies for the clinical study report (CSR) writing
Contributing to the writing and/or review product specific abstracts, publications and supporting the development of presentations for scientific meetings
Maintaining clinical and technical expertise in the therapeutic area of oncology
Attending scientific meetings pertinent to clinical science activities
And will also include:
Collaborating with the Medical Monitor on review of enrollment packets, clinical development plans and scientific presentations
Collaborating with Clinical Operations and other internal study teams to develop Informed Consent Forms, Case Report Forms and CRF instructions
Participating in ongoing clinical data review in collaboration with a cross functional team
Collaborating with Clinical Operations and other team members in the development of agendas, training materials and presentation for site visits, investigator meetings and other study related activities
Ensuring adherence to Olema’s Standard Operation Procedures and values, and maintaining the highest level of ethical behavior by leading by example
Ideal Candidate Profile >>>
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Knowledge:
Advanced degree such as a PhD or PharmD is strongly preferred
Experience in oncology clinical development is required
Comprehensive knowledge of oncology clinical trial implementation and drug development process
Demonstrated understanding of the clinical drug development process to execute drug development strategic plans and meet milestones
Experience:
A minimum of 8 years’ experience in biotech/pharmaceutical industry is required
Strong knowledge of Good Clinical Practices (GCP), FDA, and EMEA/CHMP regulations and guidelines; familiarity with other international regulatory requirements is a plus
Proactively identifying challenges/problems and proposing solutions with a strong sense of urgency
Demonstrated success motivating both internal and external team members and collaborators, fostering and nurturing teamwork
Attributes:
Strong attention to detail
Ability to interact effectively within a cross functional team
Excellent written and oral communication skills
Ability to work in a diverse and dynamic cross-functional team
Passionate about the drug-development process
Self-starter who thrives in a fast-paced environment
The base pay range for this position is expected to be $220,000 - $250,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV*
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Scientist II - Biology
Olema Oncology · San Francisco, California
Pay
$150k–165k
Setting
On-site
Scientist II - Biology
San Francisco, California
Apply
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema, with our transformation into a fully integrated oncology company well underway, top-line data from our lead program expected later this year, and our first potential commercial launch on the horizon.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the role >>> Scientist II - Biology
The Role:
Olema Oncology is currently seeking a talented and innovative Scientist II to join the Research Biology team as a screening specialist. Responsibilities of this position will include developing biology specific strategies for early-stage research projects, development and execution of biochemical and/or cellular phenotypic screening assays of new drug candidates, programming and use of liquid handler automation systems, as well as mentorship of junior scientists within the team.
You will be responsible for conducting experiments to generate high-quality data and communicate these results regularly within our project teams. You will work collaboratively within the research team to assist in the conduct of early-stage research, the goal of which is the identification of New Chemical Entities (NCEs). The Scientist II in our Research Biology organization will support adherence to all regulatory requirements and company Standard Operating Procedures (SOPs). The final level may be adjusted based on the experience of the candidate.
What You Will Do:
The selected candidate will be responsible for:
Design, optimization and execution of primary screening experiments, the goal of which is the identification of additional hits and new chemical scaffolds
Provide support for lead optimization by screening compounds and/or supporting structure activity relationship (SAR) studies involving the characterization of the biological activity of compounds in various assays
Assist in the development of biology specific strategies to help progress small-molecule oncology target discovery programs
Presentation and communication of results as part of multi-disciplinary team(s)
Manage and program automated liquid handlers (Tecan Fluent, Biomek etc.) for medium/high throughput screening assays
Assist in the identification/validation of new targets for drug discovery programs
Mentor junior team members
Work cross-functionally within the Research team, design and communicate Biology strategy and workflows to progress projects from hit to lead onwards
Apply relevant scientific principles and techniques to research problems
Maintain detailed electronic laboratory notebooks (ELN) and record results in a timely manner
Maintain knowledge of state-of-the-art principles and techniques
Present findings internally and externally and contribute to the publication of the work of the project team
May contribute to the development of patent applications as appropriate
Comply with all safety requirements
General lab duties as assigned
Ideal Candidate Profile >>>
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Knowledge:
PhD. in Cancer Biology, Pharmacology, Biochemistry, or a related field
Minimum 4+ years of relevant industry experience, with small molecule drug discovery
Oncology experience required
Hands-on experience with laboratory automation platforms such as Tecan, Hamilton, or Beckman Coulter Biomek, including programming, developing, optimizing, and troubleshooting automated methods
Experience:
Prior experience with in vitro assay development, execution, and optimization for small molecule drug screening, ideally within a drug discovery setting
Experience in designing and delivering biology strategies for research projects
Experience working on targets relevant to ER+ breast cancer biology preferred, Oncology experience required
Knowledge of breast cancer and/or cancer signaling pathways preferred
Excellent and proven project management skills
Complete understanding and wide application of technical principles, theories, concepts and techniques
Knowledge of and ability to use standard molecular and cell biology techniques are required, for example, Western blotting, microscopy, plate-based assays and qRT-PCR
Asceptic mammalian cell culture experienced is required
Knowledge of scientific principles and concepts, and current on relevant scientific literature
Good general knowledge of other related disciplines
Ability to read, analyze and interpret common scientific and technical journals
Strong publication track record in oncology, biochemistry and/or drug discovery
Experience working with high throughput screening with robotic liquid-handling automation tools is required
Experience with assay miniaturization and optimization preferred
Experience with automation software such as FluentControl and VENUS, as well as formal vendor training or certification, is strongly preferred
Proficiency with Microsoft Office. Proficiency with GraphPad Prism, or other analytical software
Experience working with Dotmatics or similar database/ELN software is preferred
Data Science/Informatics skills and experience is preferred
Attributes:
Excellent verbal and written communication and skills
Analytical thinking with problem-solving skills and the ability to adapt to changing priorities and deadlines
Effective planning, organization and time management skills including the ability to support and prioritize multiple projects
A commitment to excellence
A self-motivated, flexible and enthusiastic team player who is excited about advancing new medicines and delivering impactful drugs
Teamwork and collaboration; balances team and individual responsibilities; gives and welcomes feedback; puts success of team above own interests; supports everyone's efforts to succeed; shares expertise with others
Entrepreneurial mindset and the ability to prioritize key work-streams and requirements that will change over the near and mid-term
A demonstrated ability to make decisions on incomplete information and in areas where a high degree of professional judgment is required
Be a “difference maker” in terms of one’s professionalism and contributions
Have impeccable professional ethics, integrity and judgment
Be collegial, hard-working, confident, a self-starter and have a passion for results
The base pay range for this position is expected to be $150,000 - $165,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.
Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.
Fraud Alert: We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
Apply for this job
*
indicates a required field
First Name*
Last Name*
Preferred First Name
Email*
Phone
Country*
Phone*
Location (City)*
Locate me
Resume/CV*
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Cover Letter
Attach
Attach
Dropbox
Google Drive
Enter manually
Enter manually
Accepted file types: pdf, doc, docx, txt, rtf
Home Address*
City*
State*
Zip Code*
LinkedIn Profile*
Website
Are you legally authorized to work in the United States?*
Select...
Do you now or will you in the future require employer sponsorship?*
Select...
Submit application
Powered by
Listed by Olema Oncology for a position based in the United States. Employers on this board attest they are hiring domestically.
Select a role
The full posting opens here — pay, setting and the full description, without leaving the list.